← Back to headlines
Eli Lilly's Retatrutide Shows Strong Phase 3 Trial Results
CNBC reports that Eli Lilly has announced robust Phase 3 trial results for its drug Retatrutide, indicating promising efficacy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US Investigates Missile Strike That Killed Guests at Iranian Wedding
34m ago
Volkswagen Board Approves 100,000 Job Cuts in Major Global Restructuring
55m ago
Japan Household Spending Drops 3.6% in July for Eighth Consecutive Month
1h ago
Trump Administration Asks Supreme Court to Reinstate Mail Voting Rules
1h ago